shutterstock_728117296_-nicolo-zangirolami

Nicolo Zangirolami / Shutterstock.com

30 September 2019BiotechnologyMaxim Sobolev

Secondary patents: Moscow mewl

The Russian IP ombudsman Anatoly Semenov has written to the Russian lower house, the State Duma, drawing its attention to the increasing number of patent conflicts among pharmaceutical manufacturers in Russia and urged the Duma to legislate to address the issue.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Life sciences leaders recognised at LSPN Awards USA 2025

'Nothing can stand in the way of our work': Ukraine resumes IP system

ResMed voids sleep apnoea tech patent at PTAB

Novartis settles with licensee of blood cancer therapy day before trial

UPC orders 17-country ban on EOFlow's pumps in Insulet feud

Biotech and healthcare expert returns to Latham & Watkins

Commercialising genomic tech in Nigeria

Medical company sees $452m trade secrets award cut by 87%